{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T16:28:41Z","timestamp":1791217721424,"version":"4.1.0"},"reference-count":104,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2015,5,1]],"date-time":"2015-05-01T00:00:00Z","timestamp":1430438400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,5,1]],"date-time":"2015-05-01T00:00:00Z","timestamp":1430438400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jiac-j.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection and Chemotherapy"],"published-print":{"date-parts":[[2015,5]]},"DOI":"10.1016\/j.jiac.2015.02.012","type":"journal-article","created":{"date-parts":[[2015,3,6]],"date-time":"2015-03-06T05:50:46Z","timestamp":1425621046000},"page":"330-339","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"title":["Optimizing antibiotic therapy of bacteremia and endocarditis due to staphylococci and enterococci: New insights and evidence from the literature"],"prefix":"10.1016","volume":"21","author":[{"given":"Marco","family":"Falcone","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Russo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Venditti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jiac.2015.02.012_bib1","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1093\/cid\/cis1006","article-title":"Secular trends in nosocomial bloodstream infections: antibiotic-resistant bacteria increase the total burden of infection","volume":"56","author":"Ammerlaan","year":"2013","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiac.2015.02.012_bib2","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1128\/AAC.00462-11","article-title":"Impact of inadequate empirical therapy on the mortality of patients with bloodstream infections: a propensity score-based analysis","volume":"56","author":"Retamar","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jiac.2015.02.012_bib3","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1586\/eri.11.77","article-title":"Surveillance and management of multidrug-resistant microorganisms","volume":"9","author":"Orsi","year":"2011","journal-title":"Expert Rev Anti Infect Ther"},{"key":"10.1016\/j.jiac.2015.02.012_bib4","doi-asserted-by":"crossref","first-page":"791","DOI":"10.7326\/0003-4819-137-10-200211190-00007","article-title":"Healthcare-associated infections in adults: a reason to change the accepted definition of community-acquired infections","volume":"137","author":"Friedman","year":"2002","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jiac.2015.02.012_bib5","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.diagmicrobio.2004.05.003","article-title":"Occurrence and antimicrobial resistance pattern comparisons among bloodstream infection isolates from the SENTRY antimicrobial surveillance program (1997\u20132002)","volume":"50","author":"Biedenbach","year":"2004","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.jiac.2015.02.012_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2013.04.006","article-title":"Treatment of bacteraemia: meticillin-resistant Staphylococcus aureus (MRSA) to vancomycin-resistant S. aureus (VRSA)","volume":"42","author":"Gould","year":"2013","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.jiac.2015.02.012_bib7","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.ejim.2008.08.016","article-title":"Serious infections due to methicillin-resistant Staphylococcus aureus: an evolving challenge for physicians","volume":"20","author":"Falcone","year":"2009","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.jiac.2015.02.012_bib8","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1007\/s15010-012-0285-y","article-title":"Epidemiology, characteristics, and outcome of infective endocarditis in Italy: the Italian Study on Endocarditis","volume":"40","author":"Leone","year":"2012","journal-title":"Infection"},{"key":"10.1016\/j.jiac.2015.02.012_bib9","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1007\/s10096-011-1367-y","article-title":"Changing Italian nosocomial-community trends and heteroresistance in Staphylococcus aureus from bacteremia and endocarditis","volume":"31","author":"Campanile","year":"2012","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.jiac.2015.02.012_bib10","first-page":"923","article-title":"Staphylococcus aureus bacteremia in patients with hematologic malignancies: a retrospective case-control study","volume":"88","author":"Venditti","year":"2003","journal-title":"Haematologica"},{"key":"10.1016\/j.jiac.2015.02.012_bib11","doi-asserted-by":"crossref","first-page":"S260","DOI":"10.1086\/598185","article-title":"Clinical consensus conference: survey on Gram-positive bloodstream infections with a focus on Staphylococcus aureus","volume":"48","author":"Naber","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiac.2015.02.012_bib12","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1111\/j.1469-0691.2005.01326.x","article-title":"New strategies to identify patients harbouring antibiotic-resistant bacteria at hospital admission","volume":"12","author":"Tacconelli","year":"2006","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.jiac.2015.02.012_bib13","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S1473-3099(05)70112-2","article-title":"Community-acquired methicillin-resistant Staphylococcus aureus: an emerging threat","volume":"5","author":"Zetola","year":"2005","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.jiac.2015.02.012_bib14","doi-asserted-by":"crossref","first-page":"2976","DOI":"10.1001\/jama.290.22.2976","article-title":"Comparison of community and health-care associated methicillin-resistant Staphylococcus aureus infection","volume":"290","author":"Naimi","year":"2003","journal-title":"J\u00a0Am Med Assoc"},{"key":"10.1016\/j.jiac.2015.02.012_bib15","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1172\/JCI200523523","article-title":"Key role of poly-gamma-DL-glutamic acid in immune evasion and virulence of Staphylococcus epidermidis","volume":"115","author":"Kocianova","year":"2005","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jiac.2015.02.012_bib16","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1086\/524667","article-title":"Influence of vancomycin minimum inhibitory concentration on the treatment of methicillin-resistant Staphylococcus aureus bacteremia","volume":"46","author":"Soriano","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiac.2015.02.012_bib17","doi-asserted-by":"crossref","first-page":"3315","DOI":"10.1128\/AAC.00113-08","article-title":"Relationship between vancomycin MIC and failure among patients with methicillin resistant Staphylococcus aureus bacteremia treated with vancomycin","volume":"52","author":"Lodise","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jiac.2015.02.012_bib18","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1097\/QCO.0b013e3282f1bedd","article-title":"Management of gram-positive bacteraemia","volume":"20","author":"U\u00e7kay","year":"2007","journal-title":"Curr Opin Infect Dis"},{"key":"10.1016\/j.jiac.2015.02.012_bib19","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1093\/cid\/cit613","article-title":"Methicillin-resistant Staphylococcus aureus: an evolving pathogen","volume":"58","author":"Stryjewski","year":"2014","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiac.2015.02.012_bib20","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1001\/archinte.165.15.1756","article-title":"The burden of Staphylococcus aureus infections on hospitals in the United States: an analysis of the 2000 and 2001 Nationwide Inpatient Sample Database","volume":"165","author":"Noskin","year":"2005","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jiac.2015.02.012_bib21","first-page":"166","article-title":"Staphylococcus aureus sepsis in hospitalized non neutropenic patients: retrospective clinical and microbiological analysis","volume":"17","author":"Falcone","year":"2002","journal-title":"Ann Ital Med Int"},{"key":"10.1016\/j.jiac.2015.02.012_bib22","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1001\/archinte.162.1.25","article-title":"Treatment and outcome of Staphylococcus aureus bacteremia: a prospective study of 278 cases","volume":"162","author":"Jensen","year":"2002","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jiac.2015.02.012_bib23","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1086\/345476","article-title":"Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia: a meta-analysis","volume":"36","author":"Cosgrove","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiac.2015.02.012_bib24","doi-asserted-by":"crossref","first-page":"2658","DOI":"10.1093\/jac\/dkq373","article-title":"Importance of appropriate empirical antibiotic therapy for methicillin-resistant Staphylococcus aureus bacteraemia","volume":"65","author":"Paul","year":"2010","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.jiac.2015.02.012_bib25","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1093\/cid\/ciq146","article-title":"Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children","volume":"52","author":"Liu","year":"2011","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiac.2015.02.012_bib26","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1086\/513203","article-title":"The rationale for revising the clinical and laboratory Standards Institute vancomycin minimal inhibitory concentration interpretive criteria for Staphylococcus aureus","volume":"44","author":"Tenover","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiac.2015.02.012_bib27","doi-asserted-by":"crossref","first-page":"2398","DOI":"10.1128\/JCM.42.6.2398-2402.2004","article-title":"Relationship of MIC and bactericidal activity to efficacy of vancomycin for treatment of methicillin-resistant Staphylococcus aureus bacteremia","volume":"42","author":"Sakoulas","year":"2004","journal-title":"J\u00a0Clin Microbiol"},{"key":"10.1016\/j.jiac.2015.02.012_bib28","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1086\/423145","article-title":"Persistent bacteremia due to methicillin-resistant Staphylococcus aureus infection is associated with agr disfunction and low-level in\u00a0vitro resistance to thrombin-indiced platelet microbicidal protein","volume":"190","author":"Fowler","year":"2004","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.jiac.2015.02.012_bib29","doi-asserted-by":"crossref","first-page":"674","DOI":"10.7326\/0003-4819-115-9-674","article-title":"Slow response to vancomycin or vancomycin plus rifampin in methicillin-resistant Staphylococcus aureus endocarditis","volume":"115","author":"Levine","year":"1991","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jiac.2015.02.012_bib30","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1097\/01.md.0000091184.93122.09","article-title":"Staphylococcus aureus bacteremia: recurrence and the impact of antibiotic treatment in a prospective multicenter study","volume":"82","author":"Chang","year":"2003","journal-title":"Medicine"},{"key":"10.1016\/j.jiac.2015.02.012_bib31","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1086\/510386","article-title":"Use of vancomycin or first-generation cephalosporins for the treatment of hemodialysis-dependent patients with methicillin-susceptible Staphylococcus aureus bacteremia","volume":"44","author":"Stryjewski","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiac.2015.02.012_bib32","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1093\/cid\/cir078","article-title":"Vancomycin: we can't get there from here","volume":"52","author":"Patel","year":"2011","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiac.2015.02.012_bib33","doi-asserted-by":"crossref","first-page":"2704","DOI":"10.1128\/AAC.01708-10","article-title":"Vancomycin dosing in critically ill patients","volume":"55","author":"Roberts","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jiac.2015.02.012_bib34","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1093\/cid\/cir858","article-title":"An association between bacterial genotype combined with a high-vancomycin minimum inhibitory concentration and risk of endocarditis in methicillin-resistant Staphylococcus aureus bloodstream infection","volume":"54","author":"Miller","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiac.2015.02.012_bib35","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1093\/infdis\/jir270","article-title":"Antibiotic choice may not explain poorer outcomes in patients with Staphylococcus aureus bacteremia and high vancomycin minimum inhibitory concentrations","volume":"204","author":"Holmes","year":"2011","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.jiac.2015.02.012_bib36","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1093\/cid\/ciu183","article-title":"Effect of vancomycin minimal inhibitory concentration on the outcome of methicillin-susceptible Staphylococcus aureus endocarditis","volume":"58","author":"Cervera","year":"2014","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiac.2015.02.012_bib37","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1093\/cid\/cir935","article-title":"The clinical significance of vancomycin minimum inhibitory concentration in Staphylococcus aureus infections","volume":"54","author":"van Hal","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiac.2015.02.012_bib38","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.ijantimicag.2012.07.023","article-title":"Impact of vancomycin minimum inhibitory concentration on clinical outcomes of patients with vancomycin-susceptible Staphylococcus aureus infections","volume":"40","author":"Mavros","year":"2012","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.jiac.2015.02.012_bib39","doi-asserted-by":"crossref","first-page":"e93","DOI":"10.1016\/j.ijid.2012.08.005","article-title":"High vancomycin minimum inhibitory concentration and clinical outcomes in adults with methicillin-resistant Staphylococcus aureus infections","volume":"17","author":"Jacob","year":"2013","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.jiac.2015.02.012_bib40","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1001\/jama.2014.6364","article-title":"Association between vancomycin minimum inhibitory concentration and mortality among patients with Staphylococcus aureus bloodstream infections: a systematic review and meta-analysis","volume":"312","author":"Kalil","year":"2014","journal-title":"J\u00a0Am Med Assoc"},{"key":"10.1016\/j.jiac.2015.02.012_bib41","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1128\/AAC.35.1.79","article-title":"Failure of treatment with teicoplanin at 6 milligrams\/kilogram\/day in patients with Staphylococcus aureus intravascular infection. The infectious diseases consortium of oregon","volume":"35","author":"Gilbert","year":"1991","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jiac.2015.02.012_bib42","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1093\/infdis\/155.2.187","article-title":"Early termination of a prospective, randomized trial comparing teicoplanin and flucloxacillin for treating severe staphylococcal infections","volume":"155","author":"Calain","year":"1987","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.jiac.2015.02.012_bib43","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.diagmicrobio.2008.01.019","article-title":"In\u00a0vitro activity of daptomycin against methicillin- and multi-resistant Staphylococcus haemolyticus invasive isolates carrying different mec complexes","volume":"61","author":"Campanile","year":"2008","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.jiac.2015.02.012_bib44","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/j.1469-0691.2005.01141.x","article-title":"The need for new therapeutic agents: what is the pipeline?","volume":"11","author":"Shah","year":"2005","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.jiac.2015.02.012_bib45","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1056\/NEJMoa053783","article-title":"Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureus","volume":"355","author":"Fowler","year":"2006","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jiac.2015.02.012_bib46","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.ijantimicag.2011.09.011","article-title":"Retrospective case-control analysis of patients with staphylococcal infections receiving daptomycin or glycopeptide therapy","volume":"39","author":"Falcone","year":"2012","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.jiac.2015.02.012_bib47","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1111\/1469-0691.12470","article-title":"Early, intermediate and late infectious complications after transcatheter or surgical aortic-valve replacement: a prospective cohort study","volume":"20","author":"Falcone","year":"2014","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.jiac.2015.02.012_bib48","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.ijantimicag.2011.09.028","article-title":"New insights into methicillin-resistant Staphylococcus aureus pathogenesis, treatment and resistance","volume":"39","author":"Gould","year":"2012","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.jiac.2015.02.012_bib49","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1093\/cid\/cit112","article-title":"Early use of daptomycin versus vancomycin for methicillin-resistant Staphylococcus aureus bacteremia with vancomycin minimum inhibitory concentration >1\u00a0mg\/L","volume":"56","author":"Murray","year":"2013","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiac.2015.02.012_bib50","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.ijantimicag.2012.10.019","article-title":"Influence of early daptomycin therapy on treatment outcome of methicillin-resistant Staphylococcus aureus bacteraemia with high vancomycin minimum inhibitory concentrations","volume":"41","author":"Cheng","year":"2013","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.jiac.2015.02.012_bib51","doi-asserted-by":"crossref","first-page":"6213","DOI":"10.1128\/AAC.01563-13","article-title":"High-dose daptomycin therapy for left-sided infective endocarditis","volume":"57","author":"Carugati","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jiac.2015.02.012_bib52","doi-asserted-by":"crossref","first-page":"6192","DOI":"10.1128\/AAC.01525-12","article-title":"\u03b2-Lactams increase the antibacterial activity of daptomycin against clinical methicillin-resistant Staphylococcus aureus strains and prevent selection of daptomycin-resistant derivatives","volume":"56","author":"Mehta","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jiac.2015.02.012_bib53","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1093\/cid\/cir340","article-title":"Use of antistaphylococcal beta-lactams to increase daptomycin activity in eradicating persistent bacteremia due to methicillin-resistant Staphylococcus aureus: role of enhanced daptomycin binding","volume":"53","author":"Dhand","year":"2011","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiac.2015.02.012_bib54","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1128\/AAC.02192-12","article-title":"Multicenter evaluation of the clinical outcomes of daptomycin with and without concomitant \u03b2-lactams in patients with Staphylococcus aureus bacteremia and mild to moderate renal impairment","volume":"57","author":"Moise","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jiac.2015.02.012_bib55","doi-asserted-by":"crossref","first-page":"3006","DOI":"10.1093\/jac\/dku236","article-title":"Potent synergy of ceftobiprole plus daptomycin against multiple strains of Staphylococcus aureus with various resistance phenotypes","volume":"69","author":"Barber","year":"2014","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.jiac.2015.02.012_bib56","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1016\/j.clinthera.2014.05.061","article-title":"Antimicrobial salvage therapy for persistent staphylococcal bacteremia using daptomycin plus ceftaroline","volume":"36","author":"Sakoulas","year":"2014","journal-title":"Clin Ther"},{"key":"10.1016\/j.jiac.2015.02.012_bib57","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1186\/1471-2334-14-289","article-title":"A\u00a0randomized phase 2 trial of telavancin versus standard therapy in patients with uncomplicated Staphylococcus aureus bacteremia: the ASSURE study","volume":"14","author":"Stryjewski","year":"2014","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.jiac.2015.02.012_bib58","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1093\/cid\/ciu971","article-title":"Potential role for telavancin in bacteremic infections due to gram-positive pathogens: focus on Staphylococcus aureus","volume":"60","author":"Corey","year":"2015","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiac.2015.02.012_bib59","doi-asserted-by":"crossref","first-page":"3971","DOI":"10.1128\/AAC.00051-06","article-title":"Serum and cerebrospinal fluid concentrations of linezolid in neurosurgical patients","volume":"50","author":"Myrianthefs","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jiac.2015.02.012_bib60","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1080\/00365540410019345","article-title":"Successful treatment of disseminated cerebritis complicating methicillin-resistant Staphylococcus aureus endocarditis unresponsive to vancomycin therapy with linezolid","volume":"36","author":"Pistella","year":"2004","journal-title":"Scand J Infect Dis"},{"key":"10.1016\/j.jiac.2015.02.012_bib61","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1093\/jac\/dki355","article-title":"Linezolid versus vancomycin for Staphylococcus aureus bacteraemia: pooled analysis of randomized studies","volume":"56","author":"Shorr","year":"2005","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.jiac.2015.02.012_bib62","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1111\/j.1749-6632.2011.06330.x","article-title":"The oxazolidinones: past, present, and future","volume":"1241","author":"Shaw","year":"2011","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.jiac.2015.02.012_bib63","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1093\/cid\/ciu219","article-title":"A\u00a0phase 3 randomized double-blind comparison of ceftobiprole medocaril versus ceftazidime plus linezolid for the treatment of hospital-acquired pneumonia","volume":"59","author":"Awad","year":"2014","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiac.2015.02.012_bib64","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.diagmicrobio.2012.01.015","article-title":"In\u00a0vitro activities of ceftobiprole, dalbavancin, daptomycin, linezolid, and tigecycline against methicillin-resistant Staphylococcus aureus blood isolates: stratified analysis by vancomycin MIC","volume":"73","author":"Chong","year":"2012","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.jiac.2015.02.012_bib65","series-title":"Center for drug evaluation and research. Guidance for Industry. Acute bacterial skin and skin structure infections: developing drugs for treatment. Draft guidance [monograph]","author":"US Food and Drug Administration","year":"2010"},{"issue":"4","key":"10.1016\/j.jiac.2015.02.012_bib66","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/0002-9343(76)90715-4","article-title":"Staphylococcus aureus bacteremia","volume":"60","author":"Nolan","year":"1976","journal-title":"Am J Med"},{"key":"10.1016\/j.jiac.2015.02.012_bib67","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1128\/AAC.01021-12","article-title":"Treatment duration for uncomplicated Staphylococcus aureus bacteremia to prevent relapse","volume":"57","author":"Chong","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jiac.2015.02.012_bib68","unstructured":"ClinicalTrials.gov website. Treatment algorithm to reduce the use of vancomycin in adults with bloodstream infection (bacteremia).http:\/\/clinicaltrials.gov\/ct2\/show\/NCT01191840?term=staphylococcal+bacteremia&rank=12. [accessed 11.09.14]."},{"key":"10.1016\/j.jiac.2015.02.012_bib69","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1128\/CMR.7.1.117","article-title":"Update on clinical significance of coagulase-negative staphylococci","volume":"7","author":"Kloos","year":"1994","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.jiac.2015.02.012_bib70","doi-asserted-by":"crossref","first-page":"S114","DOI":"10.1086\/320184","volume":"32","author":"Diekema","year":"2001","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiac.2015.02.012_bib71","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.diagmicrobio.2006.08.019","article-title":"Staphylococcus haemolyticus endocarditis: clinical and microbiologic analysis of 4 cases","volume":"57","author":"Falcone","year":"2007","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.jiac.2015.02.012_bib72","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1111\/j.1469-0691.2005.01307.x","article-title":"Teicoplanin use and emergence of Staphylococcus haemolyticus: is there a link?","volume":"12","author":"Falcone","year":"2006","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.jiac.2015.02.012_bib73","doi-asserted-by":"crossref","first-page":"3880","DOI":"10.1128\/AAC.00134-09","article-title":"Activities of daptomycin and vancomycin alone and in combination with rifampin and gentamicin against biofilm-forming methicillin-resistant Staphylococcus aureus isolates in an experimental model of endocarditis","volume":"53","author":"LaPlante","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jiac.2015.02.012_bib74","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1128\/AAC.05606-11","article-title":"Efficacy of daptomycin versus vancomycin in an experimental model of foreign-body and systemic infection caused by biofilm producers and methicillin-resistant Staphylococcus epidermidis","volume":"56","author":"Dom\u00ednguez-Herrera","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jiac.2015.02.012_bib75","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.diagmicrobio.2013.01.021","article-title":"Daptomycin plus trimethoprim\/sulfamethoxazole combination therapy in post-neurosurgical meningitis caused by linezolid-resistant Staphylococcus epidermidis","volume":"76","author":"Vena","year":"2013","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.jiac.2015.02.012_bib76","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.ijantimicag.2014.12.008","article-title":"Linezolid-resistant staphylococcal bacteraemia: a multicentre case\u2013case\u2013control study in Italy","volume":"45","author":"Russo","year":"2015","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.jiac.2015.02.012_bib77","doi-asserted-by":"crossref","first-page":"S194","DOI":"10.1093\/cid\/cis562","article-title":"Ceftaroline potency among 9 US Census regions: report from the 2010 AWARE Program","volume":"55","author":"Flamm","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiac.2015.02.012_bib78","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1093\/jac\/dks006","article-title":"Methicillin-resistant Staphylococcus aureus bacteraemia and endocarditis treated with ceftaroline salvage therapy","volume":"67","author":"Ho","year":"2012","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.jiac.2015.02.012_bib79","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1128\/AAC.24.1.70","article-title":"Self-transmissible plasmids in staphylococci that encode resistance to aminoglycosides","volume":"24","author":"Archer","year":"1983","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jiac.2015.02.012_bib80","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.1016\/j.ijantimicag.2008.08.001","article-title":"Non-staphylococcal Gram-positive bacteraemia without a known source","volume":"32","author":"Hoen","year":"2008","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.jiac.2015.02.012_bib81","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s100960000429","article-title":"Case\u2013control study of risk factors for the development of enterococcal bacteremia","volume":"20","author":"Caballero-Granado","year":"2001","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.jiac.2015.02.012_bib82","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1128\/AAC.43.3.639","article-title":"Efficacy of ampicillin plus ceftriaxone in treatment of experimental endocarditis due to Enterococcus faecalis strains highly resistant to aminoglycosides","volume":"4","author":"Gavald\u00e0","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jiac.2015.02.012_bib83","doi-asserted-by":"crossref","first-page":"574","DOI":"10.7326\/0003-4819-146-8-200704170-00008","article-title":"Brief communication: treatment of Enterococcus faecalis endocarditis with ampicillin plus ceftriaxone","volume":"146","author":"Gavald\u00e0","year":"2007","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jiac.2015.02.012_bib84","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1093\/cid\/cit052","article-title":"Ampicillin plus ceftriaxone is as effective as ampicillin plus gentamicin for treating enterococcus faecalis infective endocarditis","volume":"56","author":"Fern\u00e1ndez-Hidalgo","year":"2013","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiac.2015.02.012_bib85","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1056\/NEJM198807213190307","article-title":"Plasmid-mediated resistance to vancomycin and teicoplanin in Enterococcus faecium","volume":"319","author":"Leclercq","year":"1988","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jiac.2015.02.012_bib86","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1128\/AAC.33.9.1588","article-title":"In\u00a0vitro susceptibility studies of vancomycin-resistant Enterococcus faecalis","volume":"33","author":"Sahm","year":"1989","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jiac.2015.02.012_bib87","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1086\/591861","article-title":"NHSN annual update: antimicrobial-resistant pathogens associated with healthcare-associated infections: annual summary of data reported to the national healthcare safety network at the centers for disease control and prevention, 2006\u20132007","volume":"29","author":"Hidron","year":"2008","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.jiac.2015.02.012_bib88","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1086\/430909","article-title":"Comparison of mortality associated with vancomycin-resistant and vancomycin-susceptible enterococcal bloodstream infections: a meta-analysis","volume":"41","author":"Diaz Granados","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiac.2015.02.012_bib89","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1186\/s12879-014-0687-9","article-title":"Daptomycin versus linezolid for treatment of vancomycin-resistant enterococcal bacteremia: systematic review and meta-analysis","volume":"14","author":"Chuang","year":"2014","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.jiac.2015.02.012_bib90","doi-asserted-by":"crossref","first-page":"S33","DOI":"10.1016\/j.ijantimicag.2010.11.011","article-title":"Pharmacokinetic\/pharmacodynamic (PK\/PD) considerations in the management of Gram-positive bacteraemia","volume":"36","author":"Scaglione","year":"2010","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.jiac.2015.02.012_bib91","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1097\/00007691-199908000-00003","article-title":"Non steady state and steady state PKS Bayesian forecasting and vancomycin pharmacokinetics in ICU adult patients","volume":"21","author":"Polard","year":"1999","journal-title":"Ther Drug Monit"},{"key":"10.1016\/j.jiac.2015.02.012_bib92","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s00134-006-0470-5","article-title":"Pharmacokinetic\/pharmacodynamic analysis of vancomycin in ICU patients","volume":"33","author":"Del Mar Fern\u00e1ndez de Gatta Garcia","year":"2007","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.jiac.2015.02.012_bib93","doi-asserted-by":"crossref","first-page":"S100","DOI":"10.1097\/00003246-200104001-00009","article-title":"Antimicrobial management strategies for Gram-positive bacterial resistance in the intensive care unit","volume":"29","author":"Schentag","year":"2001","journal-title":"Crit Care Med"},{"key":"10.1016\/j.jiac.2015.02.012_bib94","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1086\/520182","article-title":"Impact of infectious diseases specialists and microbiological data on the appropriateness of antimicrobial therapy for bacteremia","volume":"29","author":"Byl","year":"1999","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiac.2015.02.012_bib95","doi-asserted-by":"crossref","first-page":"2460","DOI":"10.1128\/AAC.45.9.2460-2467.2001","article-title":"Continuous versus intermittent infusion of vancomycin in severe staphylococcal infections: prospective multicenter randomized study","volume":"45","author":"Wysocki","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jiac.2015.02.012_bib96","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1159\/000007092","article-title":"Continuous infusion of vancomycin in methicillin-resistant staphylococcus infection","volume":"44","author":"Di Filippo","year":"1998","journal-title":"Chemotherapy"},{"key":"10.1016\/j.jiac.2015.02.012_bib97","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1128\/AAC.48.1.63-68.2004","article-title":"In\u00a0vivo pharmacodynamic activity of daptomycin","volume":"48","author":"Safdar","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jiac.2015.02.012_bib98","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1007\/s10156-013-0559-z","article-title":"Variability of pharmacokinetic parameters in patients receiving different dosages of daptomycin: is therapeutic drug monitoring necessary?","volume":"19","author":"Falcone","year":"2013","journal-title":"J\u00a0Infect Chemother"},{"key":"10.1016\/j.jiac.2015.02.012_bib99","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/S0732-8893(03)00119-6","article-title":"Daptomycin against multiple drug-resistant Staphylococcus and Enterococcus isolates in an in\u00a0vitro pharmacodynamic model with simulated endocardial vegetations","volume":"47","author":"Cha","year":"2003","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.jiac.2015.02.012_bib100","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1093\/cid\/cit582","article-title":"Considerations for higher doses of daptomycin in critically ill patients with methicillin-resistant Staphylococcus aureus bacteremia","volume":"57","author":"Falcone","year":"2013","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiac.2015.02.012_bib101","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1093\/cid\/ciu233","article-title":"Reply to Di Paolo et\u00a0al","volume":"58","author":"Falcone","year":"2014","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiac.2015.02.012_bib102","doi-asserted-by":"crossref","first-page":"3162","DOI":"10.1128\/AAC.02355-14","article-title":"Simplified equations using two concentrations to calculate area under the curve for antimicrobials with concentration-dependent pharmacodynamics: daptomycin as a motivating example","volume":"58","author":"Pai","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jiac.2015.02.012_bib103","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1093\/eurheartj\/ehp285","volume":"30","author":"Habib","year":"2009","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jiac.2015.02.012_bib104","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1097\/QCO.0000000000000012","article-title":"Aminoglycosides: how should we use them in the 21st century?","volume":"26","author":"Jackson","year":"2013","journal-title":"Curr Opin Infect Dis"}],"container-title":["Journal of Infection and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X15000550?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X15000550?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T18:53:46Z","timestamp":1761159226000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1341321X15000550"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5]]},"references-count":104,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2015,5]]}},"alternative-id":["S1341321X15000550"],"URL":"https:\/\/doi.org\/10.1016\/j.jiac.2015.02.012","relation":{},"ISSN":["1341-321X"],"issn-type":[{"value":"1341-321X","type":"print"}],"subject":[],"published":{"date-parts":[[2015,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Optimizing antibiotic therapy of bacteremia and endocarditis due to staphylococci and enterococci: New insights and evidence from the literature","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection and Chemotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jiac.2015.02.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}